Awardee OrganizationNEW JERSEY INSTITUTE OF TECHNOLOGY
Description
Abstract Text
Abstract
Cross-linking mass spectrometry (CLMS) is playing an increasingly important role in determining protein 3D
structures. By structural elucidation of cross-links (i.e., cross-linked peptides resulting from digestion of cross-
linked proteins or protein complexes), CLMS can determine distance constraints between specific functional
groups that can be used to guide structural modeling and docking of proteins and protein complexes. Further
quantitative analysis of cross-links would allow exploration of dynamic protein conformational changes in
solution, a challenging task for traditional structural biology techniques. However, absolute quantitative analysis
of cross-links is very challenging, due to lack of standard cross-linked peptides. To tackle this issue, we propose
to develop a novel absolute quantitative cross-linking mass spectrometry (aqCLMS) using coulometric mass
spectrometry (CMS), a method recently developed in our laboratory for absolute quantitation without using
standards. It is based on electrochemical oxidation of cross-links to produce electric current and the
measurement of the oxidation yield by MS, therefore eliminating the need of using any standards for absolute
quantitation. An aqCLMS method would enable: 1) quantitative analysis and comparison among all cross-links
at one particular or different conformational states, greatly increasing information about residue accessibilities
and their distance constraints in comparison with traditional CLMS; 2) evaluating absolute quantities of transient
protein complexes that form during a particular biological event, which is difficult to measure using existing
techniques. We foresee that our aqCLMS method is very informative in probing dynamic protein conformations,
which would have high impact in structural biology and drug discovery.
In this project, we propose to use this aqCLMS approach to probe and quantify the conformational structures
of PROteolysis TArgeting Chimera (PROTAC)-mediated complexes, specifically BRD4-PROTAC-CRBN. A key
step in PROTAC is the formation of an induced protein complex where a degrader molecule recruits an E3 ligase
to the protein of interest (POI) to facilitate the ubiquitination of the POI, eventually leading to its proteasomal
degradation. Thus, rational design of PROTACs will require a structural understanding of target-PROTAC-E3
ternary complexes, which is, however, still very limited. In this project, in combination with advanced molecular
dynamics (MD) simulations, aqCLMS would provide deep insights into the dynamic nature of the PROTAC-
mediated ternary structure ensemble beyond what is seen in the crystal structures.
Public Health Relevance Statement
Narrative
Cross-linking mass spectrometry (CLMS), a powerful technique for determining protein
conformational structures, lacks capability for absolute quantitation of cross-links (i.e., cross-
linked peptides). This proposal aims to develop a novel absolute quantitative cross-linking mass
spectrometry (aqCLMS) based on the combination of CLMS with coulometric mass spectrometry
(CMS). We also propose to apply aqCLMS, coupled with advanced molecular dynamics (MD)
simulation, to study dynamic conformations of PROTAC-mediated ternary complexes for
improved accuracy for their structural determination.
No Sub Projects information available for 5R21GM148874-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21GM148874-02
Patents
No Patents information available for 5R21GM148874-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21GM148874-02
Clinical Studies
No Clinical Studies information available for 5R21GM148874-02
News and More
Related News Releases
No news release information available for 5R21GM148874-02
History
No Historical information available for 5R21GM148874-02
Similar Projects
No Similar Projects information available for 5R21GM148874-02